Published in J Allergy Clin Immunol on February 01, 2010
Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol (2011) 1.26
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol (2013) 1.16
Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog (2011) 1.11
Cytokine/anti-cytokine therapy - novel treatments for asthma? Br J Pharmacol (2011) 1.11
Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog (2011) 1.01
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One (2012) 0.90
Advances in pediatric asthma in 2010: addressing the major issues. J Allergy Clin Immunol (2011) 0.90
Immune responses to self-antigens in asthma patients: clinical and immunopathological implications. Hum Immunol (2012) 0.88
TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life. PLoS One (2012) 0.85
Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis. J Biol Chem (2014) 0.84
Elucidating novel disease mechanisms in severe asthma. Clin Transl Immunology (2016) 0.84
Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells. PLoS One (2011) 0.84
Perinatal factors in neonatal and pediatric lung diseases. Expert Rev Respir Med (2013) 0.81
Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice. PLoS One (2012) 0.81
Role of dendritic cells: a step forward for the hygiene hypothesis. Cell Mol Immunol (2010) 0.80
Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. Mucosal Immunol (2013) 0.79
An alternate STAT6-independent pathway promotes eosinophil influx into blood during allergic airway inflammation. PLoS One (2011) 0.79
Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice. Infect Immun (2013) 0.78
Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. JCI Insight (2016) 0.76
Neonatal Streptococcus pneumoniae infection may aggravate adulthood allergic airways disease in association with IL-17A. PLoS One (2015) 0.76
TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD. PLoS One (2016) 0.75
Chlamydial infection and asthma: is early allergic sensitization the only mechanism? J Allergy Clin Immunol (2010) 0.75
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet (2012) 4.94
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2014) 3.52
Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet (2011) 3.21
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16
Eosinophils: changing perspectives in health and disease. Nat Rev Immunol (2012) 2.69
Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology (2006) 2.67
Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest (2010) 2.29
Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A (2009) 2.28
Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol (2007) 2.27
Cyclic alternating pattern in sleep and its relationship to creativity. Sleep Med (2011) 2.21
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19
Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax (2006) 2.18
Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med (2004) 2.15
Limbal relaxing incisions versus on-axis incisions to reduce corneal astigmatism at the time of cataract surgery. J Cataract Refract Surg (2005) 2.12
Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol (2003) 2.06
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04
Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med (2007) 1.91
Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology (2004) 1.87
Interferon-ε protects the female reproductive tract from viral and bacterial infection. Science (2013) 1.73
Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med (2005) 1.68
Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol (2013) 1.67
Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic inflammation. J Immunol (2009) 1.67
Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int (2012) 1.64
Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol (2004) 1.62
Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology (2013) 1.60
Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol (2011) 1.57
Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology (2007) 1.54
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood (2007) 1.52
Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J Urol (2012) 1.52
Laryngeal sensory dysfunction in laryngeal hypersensitivity syndrome. Respirology (2013) 1.48
The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest (2012) 1.48
Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses. Am J Respir Crit Care Med (2009) 1.47
Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol (2002) 1.47
Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am J Respir Cell Mol Biol (2006) 1.47
A role for eosinophils in airway remodelling in asthma. Trends Immunol (2004) 1.44
Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine (2009) 1.44
Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol (2011) 1.44
The "classical" ovalbumin challenge model of asthma in mice. Curr Drug Targets (2008) 1.42
Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood (2006) 1.42
Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol (2006) 1.40
Comparison of antigen detection and quantitative PCR in the detection of chlamydial infection in koalas (Phascolarctos cinereus). Vet J (2012) 1.39
Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev (2009) 1.38
Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nat Med (2007) 1.36
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol (2007) 1.34
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2009) 1.32
NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol (2010) 1.32
Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun (2004) 1.30
Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review. FEMS Microbiol Rev (2004) 1.28
Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust (2003) 1.27
Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med (2003) 1.25
TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol (2008) 1.25
Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med (2005) 1.24
Impaired resistance in early secondary Nippostrongylus brasiliensis infections in mice with defective eosinophilopoeisis. Int J Parasitol (2007) 1.23
Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol (2008) 1.23
Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod (2008) 1.22
Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol (2006) 1.22
A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol (2011) 1.22
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci U S A (2013) 1.21
Marked host specificity and lack of phylogeographic population structure of Campylobacter jejuni in wild birds. Mol Ecol (2013) 1.20
The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med (2013) 1.20
Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med (2003) 1.20
Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther (2003) 1.20
The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol (2008) 1.19
Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci U S A (2004) 1.18
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol (2013) 1.16
Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers. J Voice (2010) 1.15
Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med (2011) 1.14
Inflammometry: the current state of play. Thorax (2012) 1.14
S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol (2006) 1.14
Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J (2013) 1.14
Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol (2003) 1.13
Emerging roles of pulmonary macrophages in driving the development of severe asthma. J Leukoc Biol (2012) 1.11
Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog (2011) 1.11
Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis (2009) 1.11
Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther (2008) 1.11
Cytokine/anti-cytokine therapy - novel treatments for asthma? Br J Pharmacol (2011) 1.11
Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity. J Agric Food Chem (2005) 1.11